Yonsei Med J.  2016 Mar;57(2):283-290. 10.3349/ymj.2016.57.2.283.

A Simple, Reproducible, Inexpensive, Yet Old-Fashioned Method for Determining Phagocytic and Bactericidal Activities of Macrophages

• Kaneko M
• Emoto Y
• Emoto M

• KMID: 2374030
• DOI: http://doi.org/10.3349/ymj.2016.57.2.283

Abstract

Macrophages (Mphi) play a pivotal role in the protection system by recognizing and eliminating invading pathogenic bacteria. Phagocytosis and the killing of invading bacteria are major effector functions of Mphi. Although the phagocytic and bactericidal activities of Mphi have been analyzed via several methods using a light microscope, a fluorescence microscope, or a fluorescence-activated cell sorter, expensive materials and equipment are usually required, and the methods are rather complicated. Moreover, it is impossible to determine both the phagocytic and bactericidal activities of Mphi simultaneously using these methods. In this review, we describe a simple, reproducible, inexpensive, yet old-fashioned method (antibiotic protection assay) for determining the phagocytic and bactericidal activities of Mphi.

Keyword

Anti-bacterial agent; gentamicin; macrophage; phagocytosis

MeSH Terms

Anti-Bacterial Agents/*pharmacology
Gentamicins/*pharmacology
Macrophages/*drug effects
Phagocytosis/*drug effects
Anti-Bacterial Agents
Gentamicins

Figure

• 

  Fig. 1 An antibiotic protection assay. Two sets of Mϕ (one for the determination of phagocytic activity and the other for the determination of bactericidal activity) are incubated for a short period of time with bacteria in CM to be engulfed by Mϕ. To determine phagocytic activity, Mϕ are washed with CM containing antibiotic to kill extracellular bacteria followed by CM. They are then treated with saponin to release bacteria from Mϕ, and CFUs are determined [CFU (P)]. To determine bactericidal activity, Mϕ infected with bacteria are further incubated for a short period of time in CM containing antibiotic to kill intracellular bacteria followed by CM. They are then treated with saponin, and the number of viable bacteria in Mϕ is determined by counting the CFU after washing with CM [CFU (B)]. Bactericidal activity of Mϕ can be calculated by comparing CFU (P) with CFU (B). CM, complete medium; CFU, colony-forming units; Mϕ, macrophages.

• 

  Fig. 2 Influence of antibiotics with high and low molecular weight on bacteria in Mϕ. Mϕ engulf bacteria by forming specific vacuoles called phagosomes. An antibiotic with a low molecular weight penetrates into the cytosol and kills both extracellular and intracellular bacteria (A). An antibiotic with a high molecular weight is unable to penetrate into the cytosol and thus kills only extracellular bacteria (B). Mϕ, macrophages.

• 

  Fig. 3 Killing mechanism of GM. GM inhibits translation of mRNA by binding to the 30S subunit of the ribosome. The irreversible binding of GM to the ribosome causes the misreading of the codons, which in turn causes an error in the proofreading process of translation, leading to incorrect protein expression and bacterial cell death. GM, gentamicin.

• 

  Fig. 4 Experimental procedure for determining the phagocytic and bactericidal activities of Mϕ using a GM protection assay. Two tissue culture plates are prepared; one to determine phagocytic activity and the other to determine bactericidal activity. Mϕ are incubated in CM for 120 min to adhere to the bottom of tissue culture plates and then incubated with bacteria (Mϕ:bacteria=1:10) for a short period of time in CM to ingest bacteria. To remove non-ingested bacteria, cells are washed three times with CM containing the optimal concentration of GM followed by CM, and CFUs are then determined [CFU (P)]. Infected Mϕ incubated in another plate are further incubated for a short period of time in CM containing the optimal concentration of GM. During this period, engulfed bacteria are killed by Mϕ. Cells are washed three times with CM, and the number of viable bacteria in Mϕ can also be determined by counting CFU after washing with CM [CFU (B)]. Bactericidal activity of Mϕ can be calculated by comparing CFU (P) with CFU (B) after saponin treatment and sonication. GM, gentamicin; CM, complete medium; CFU, colony-forming units; Mϕ, macrophages.

• 

  Fig. 5 Influence of GM on Mϕ. (A) RAW264 were incubated with CM containing various concentrations of GM for 48 h, and the morphological changes were observed under phase contrast microscope. Representative data from two independent experiments are shown. (B) RAW264 were incubated with CM containing various concentrations of GM for 48 h, and their viabilities were enumerated via trypan blue exclusion test. Data are presented as mean±SD of two independent experiments. *p<0.05: 0 vs. 100 or 500. N.D., not detectable; GM, gentamicin; CM, complete medium; Mϕ, macrophages.

• 

  Fig. 6 Effects of saponin and sonication on plasma and phagosomal membranes of Mϕ. Saponin interacts with cholesterols residing in plasma and phagosomal membranes and forms pores in lipid bilayers. After sonication, internalized bacteria are released. Mϕ, macrophages.

Reference

1. Doherty GJ, McMahon HT. Mechanisms of endocytosis. Annu Rev Biochem. 2009; 78:857–902.

2. Underhill DM, Goodridge HS. Information processing during phagocytosis. Nat Rev Immunol. 2012; 12:492–502.

3. Garin J, Diez R, Kieffer S, Dermine JF, Duclos S, Gagnon E, et al. The phagosome proteome: insight into phagosome functions. J Cell Biol. 2001; 152:165–180.

4. Fang FC. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rev Microbiol. 2004; 2:820–832.

5. Ray K, Marteyn B, Sansonetti PJ, Tang CM. Life on the inside: the intracellular lifestyle of cytosolic bacteria. Nat Rev Microbiol. 2009; 7:333–340.

6. Buchmeier NA, Heffron F. Intracellular survival of wild-type Salmonella typhimurium and macrophage-sensitive mutants in diverse populations of macrophages. Infect Immun. 1989; 57:1–7.

7. Skerrett SJ, Martin TR. Recombinant murine interferon-gamma reversibly activates rat alveolar macrophages to kill Legionella pneumophila. J Infect Dis. 1992; 166:1354–1361.

8. Inoue S, Itagaki S, Amano F. Intracellular killing of Listeria monocytogenes in the J774.1 macrophage-like cell line and the lipopolysaccharide (LPS)-resistant mutant LPS1916 cell line defective in the generation of reactive oxygen intermediates after LPS treatment. Infect Immun. 1995; 63:1876–1886.

9. Stevanin TM, Moir JW, Read RC. Nitric oxide detoxification systems enhance survival of Neisseria meningitidis in human macrophages and in nasopharyngeal mucosa. Infect Immun. 2005; 73:3322–3329.

10. Emoto M, Yoshida T, Fukuda T, Kawamura I, Mitsuyama M, Kita E, et al. Alpha-galactosylceramide promotes killing of Listeria monocytogenes within the macrophage phagosome through invariant NKT-cell activation. Infect Immun. 2010; 78:2667–2676.

11. Mandell GL. Interaction of intraleukocytic bacteria and antibiotics. J Clin Invest. 1973; 52:1673–1679.

12. Lobo MC, Mandell GL. The effect of antibiotics on Escherichia coli ingested by macrophages. Proc Soc Exp Biol Med. 1973; 142:1048–1050.

13. Vaudaux P, Waldvogel FA. Gentamicin antibacterial activity in the presence of human polymorphonuclear leukocytes. Antimicrob Agents Chemother. 1979; 16:743–749.

14. Bryskier A. Antimicrobial agents. 1st ed. Washington, DC: ASM Press;2005.

15. Vakulenko SB, Mobashery S. Versatility of aminoglycosides and prospects for their future. Clin Microbiol Rev. 2003; 16:430–450.

16. Klein JO, Eickhoff TC, Finland M. Gentamicin: activity in vitro and observations in 26 patients. Am J Med Sci. 1964; 248:528–544.

17. Waitz JA, Weinstein MJ. Recent microbiological studies with gentamicin. J Infect Dis. 1969; 119:355–360.

18. Espaze EP, Reynaud AE. Antibiotic susceptibilities of Listeria: in vitro studies. Infection. 1988; 16:Suppl 2. S160–S164.

19. Ho YI, Chan CY, Cheng AF. In-vitro activities of aminoglycoside-aminocyclitols against mycobacteria. J Antimicrob Chemother. 1997; 40:27–32.

20. Wilson G, Easow JM, Mukhopadhyay C, Shivananda PG. Isolation & antimicrobial susceptibility of Shigella from patients with acute gastroenteritis in Western Nepal. Indian J Med Res. 2006; 123:145–150.

21. Schmid S, Knoblauch K. Digestive Organs. In : Bühlmann AA, Froesch ER, editors. Pathophysiology. 1st ed. New York: Springer-Verlag;1979. p. 261–315.

22. Tseng JT, Bryan LE, Van den Elzen HM. Mechanisms and spectrum of streptomycin resistance in a natural population of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1972; 2:136–141.

23. Ximenes J, Bassoi ON, de Menezes JP, Fry W. Activity of amikacin, gentamicin and kanamycin against Pseudomonas aeruginosa. J Int Med Res. 1976; 4:165–175.

24. de Melo MA, Pechère JC. Effect of mucin on Campylobacter jejuni association and invasion on HEp-2 cells. Microb Pathog. 1988; 5:71–76.

25. Portnoy DA, Jacks PS, Hinrichs DJ. Role of hemolysin for the intracellular growth of Listeria monocytogenes. J Exp Med. 1988; 167:1459–1471.

26. Shaw JH, Falkow S. Model for invasion of human tissue culture cells by Neisseria gonorrhoeae. Infect Immun. 1988; 56:1625–1632.

27. Drevets DA, Canono BP, Leenen PJ, Campbell PA. Gentamicin kills intracellular Listeria monocytogenes. Infect Immun. 1994; 62:2222–2228.

28. Ohya S, Xiong H, Tanabe Y, Arakawa M, Mitsuyama M. Killing mechanism of Listeria monocytogenes in activated macrophages as determined by an improved assay system. J Med Microbiol. 1998; 47:211–215.

29. Francis G, Kerem Z, Makkar HP, Becker K. The biological action of saponins in animal systems: a review. Br J Nutr. 2002; 88:587–605.

30. Armstrong JA, Hart PD. Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J Exp Med. 1971; 134(3 Pt 1):713–740.

31. Herbst S, Schaible UE, Schneider BE. Interferon gamma activated macrophages kill mycobacteria by nitric oxide induced apoptosis. PLoS One. 2011; 6:e19105.

32. Drevets DA, Campbell PA. Roles of complement and complement receptor type 3 in phagocytosis of Listeria monocytogenes by inflammatory mouse peritoneal macrophages. Infect Immun. 1991; 59:2645–2652.

33. Drevets DA, Canono BP, Campbell PA. Listericidal and nonlistericidal mouse macrophages differ in complement receptor type 3-mediated phagocytosis of L. monocytogenes and in preventing escape of the bacteria into the cytoplasm. J Leukoc Biol. 1992; 52:70–79.

34. Utermöhlen O, Karow U, Löhler J, Krönke M. Severe impairment in early host defense against Listeria monocytogenes in mice deficient in acid sphingomyelinase. J Immunol. 2003; 170:2621–2628.

35. Sharma L, Wu W, Dholakiya SL, Gorasiya S, Wu J, Sitapara R, et al. Assessment of phagocytic activity of cultured macrophages using fluorescence microscopy and flow cytometry. Methods Mol Biol. 2014; 1172:137–145.

36. Kaneko M, Kanayama Y, Emoto Y, Emoto M. Several methods for determination of phagocytic and killing activities of macrophages against Listeria monocytogenes. In : Vicario T, editor. Listeria monocytogenes: incidence, growth behavior and control. 1st ed. New York: Nova Science Publishers;2015. p. 15363–163.

37. Peck R. A one-plate assay for macrophage bactericidal activity. J Immunol Methods. 1985; 82:131–140.

38. Mancuso P, Peters-Golden M, Goel D, Goldberg J, Brock TG, Greenwald-Yarnell M, et al. Disruption of leptin receptor-STAT3 signaling enhances leukotriene production and pulmonary host defense against pneumococcal pneumonia. J Immunol. 2011; 186:1081–1090.

39. Domingo-Gonzalez R, Katz S, Serezani CH, Moore TA, Levine AM, Moore BB. Prostaglandin E2-induced changes in alveolar macrophage scavenger receptor profiles differentially alter phagocytosis of Pseudomonas aeruginosa and Staphylococcus aureus post-bone marrow transplant. J Immunol. 2013; 190:5809–5817.